PHT and Lionbridge Present Webinar on Strategies for Conducting Successful Clinical Trials in Emerging Markets
Global Experts Offer Proven Strategies for Managing Clinical Trials in India, China, Eastern Europe and Latin America
BOSTON, Mass and Waltham, MASS– September 18, 2009 – PHT Corporation and Lionbridge Technologies, Inc. (NASDAQ:LIOX) are sponsoring a webinar to reveal the crucial elements required to avoid operational complexities and financial risk when conducting clinical trials in emerging countries. The webinar will be held on September 23, 2009 at 12 noon EDT. Interested participants can register and gain more information at http://bit.ly/jwHIw.
PHT is the leading provider of ePRO (electronic patient reported outcome) solutions used in more than 400 clinical trials worldwide. Lionbridge is a market leader in language services with expertise in translation, linguistic validation, and interpretation services for medical device developers, pharmaceutical companies, and CROs.
Dwight Cooper, Vice President of Client Services at PHT Corporation, explained, “India, China, Eastern Europe and Latin America are commonly regarded as emerging markets for clinical trials, even though large pharmas have been leveraging these regions for years. The availability of large, diverse populations of treatment-naïve subjects imply cost savings and increasing levels of compliance. But they also carry increased operational complexities and financial risk. In this webinar, we will use our extensive clinical trial data experience to describe how to design a startup critical path to prevent unnecessary financial and data risks for sponsors and CROs.”
“We’re delighted to offer our global expertise by co-hosting this Life Sciences Webinar with PHT,” commented Mark Wade, Life Sciences Global Practice Leader at Lionbridge. “Lionbridge and PHT understand the considerations and modifications necessary when conducting clinical trials in emerging regions. We look forward to sharing our strategies for success in this joint presentation.”
PHT and Lionbridge will feature a sample study of a large Phase III trial conducted in more than 20+ countries – including emerging regions. The presentation will review the logistical issues involved with collecting clinical trial data from emerging markets such as India, China and Eastern Europe, and describe best practices for conducting clinical trials that comply with worldwide regulations and guidance for data quality and integrity traceability.
Webinar:
“Successful Execution of Clinical Trials in Emerging Markets: Operational Best Practices for Clinical Data Capture.”
Date and Time:
Wednesday, September 23, 2009. 12 noon ET.
Presenters:
Dwight Cooper, VP Client Services at PHT Corporation
Mark P. Wade, Global Practice Leader at Lionbridge Life Sciences
To Register: For more information or to register for this important webinar visit http://bit.ly/jwHIw.
About Lionbridge Life Sciences
Lionbridge Life Sciences specializes in language services for medical device developers, pharmaceutical companies, and CROs, delivering high-quality translation, linguistic validation, and interpretation services in over 150 languages. Life Sciences clients benefit from Lionbridge’s highly specialized network of medically trained linguists, operating from solution centers in 26 countries.
About Lionbridge
Lionbridge Technologies, Inc. (NASDAQ: LIOX) is a provider of translation, development and testing services. Lionbridge combines global resources with proven program management methodologies to serve as an outsource partner throughout a client's product and content lifecycle - from development to translation, testing and maintenance. Global organizations rely on Lionbridge services to increase international market share, speed adoption of global products and content, and enhance their return on enterprise applications and IT system investments. Based in Waltham, Mass., Lionbridge maintains solution centers in 26 countries and provides services under the Lionbridge and VeriTest brands. To learn more, visit http://www.lionbridge.com.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad® Tablet deliver the voice of the patient, in 88 per Dwight today languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 known NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at www.phtcorp.com.
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Media Contacts:
For Lionbridge– Sara Buda, VP, Corporate Communications, +1 781-434-6190, sara.buda@lionbridge.com
For PHT Corporation – Brenda Nashawaty, bnashawaty@phtcorp.com, +1 617-688-3253
###
